Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Healthcare
/
Global Health
MEDANTA
Global Health
Digital Platforms And Aging Demographics Will Transform Premium Care
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 15 Analysts
Published
03 Jul 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
₹1,536.00
9.9% undervalued
intrinsic discount
08 Aug
₹1,384.70
Loading
1Y
28.8%
7D
0.8%
Author's Valuation
₹1.5k
9.9% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
₹1.5k
9.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
69b
2018
2020
2022
2024
2025
2026
2028
Revenue ₹68.8b
Earnings ₹10.1b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
15.24%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹10.06b
Earnings '28
x
58.82x
PE Ratio '28
=
₹591.89b
Market Cap '28
₹591.89b
Market Cap '28
/
269.19m
No. shares '28
=
₹2.20k
Share Price '28
₹2.20k
Share Price '28
Discounted to 2025 @ 12.73% p.a.
=
₹1.53k
Fair Value '25